Connect Biopharma Holdings Limited (CNTB) Return on equity 2023–2025
Connect Biopharma Holdings Limited (CNTB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-132.2%FY2025 · since FY2023: -61.2% → -132.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -132.2% | -115.2 pp |
| FY2024 | -17.0% | +44.2 pp |
| FY2023 | -61.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice